Supposing that evolvability stimulated by APN might be manifest as AD through the antagonistic pleiotropy in aging, it is predicted that an attractive alternate therapy strategy might focus on the antagonistic pleiotropy mechanism (Figure 2). The gene discussed is ANPEP; the disease is Alzheimer disease.